Remdesivir and Dexamethasone: The Two Eligible Candidate Drugs Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) Infection

Lots of research based on drug designing as well as in silico study, cell culture/animal model study, and the clinical trials are being conducted perceive the suitable therapeutic drugs and to develop vaccines in order to alleviate the ongoing COVID-19 pandemic caused by the severe acute respiratory...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yusra Binte Sikandar, Ilora Shabnam Kheya, Rashed Noor
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wolters Kluwer Medknow Publications 2020-01-01
סדרה:	Biomedical Research Journal
נושאים:	antiviral drugs covid-19 pandemic dexamethasone remdesivir
גישה מקוונת:	http://www.brjnmims.org/article.asp?issn=2349-3666;year=2020;volume=7;issue=2;spage=29;epage=33;aulast=Sikandar
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!